About Cytek Biosciences
Cytek Biosciences (NASDAQ:CTKB) specializes in the development and manufacturing of advanced flow cytometry products. Its cutting-edge solutions are designed to support researchers and clinicians in various fields such as immunology, cell biology, and cancer research by providing detailed cell analysis. Cytek's product portfolio includes innovative flow cytometers that offer high-dimensional data while maintaining ease of use and cost-effectiveness. At the heart of Cytek's objectives is the commitment to enhancing precision medicine and improving patient outcomes through more accessible and advanced cellular analysis technologies. Through continuous innovation and strategic partnerships, Cytek aims to expand its global footprint and drive advancements in life science research and clinical diagnostics.
Snapshot
Operations
Products and/or services of Cytek Biosciences
- Full spectrum flow cytometry tools, providing detailed cell analysis for life science research and clinical applications.
- Aurora and Northern Lights advanced cytometers, featuring high sensitivity and resolution for complex cell profiling.
- SpectroFlo software, offering intuitive data acquisition and analysis for flow cytometry.
- Comprehensive support and services, including training, technical support, and maintenance for flow cytometry equipment.
- Custom panel design services, assisting researchers in developing specific fluorescent panels for targeted cell analysis.
- Flow cytometry reagents, supplying a wide range of dyes and antibodies for various research needs.
Cytek Biosciences executive team
- Dr. Wenbin Jiang Ph.D.President, CEO & Chairman of the Board
- Mr. William D. McCombeChief Financial Officer
- Dr. Ming Yan Ph.D.CTO & Director
- Ms. Valerie T. Barnett J.D.Chief Legal Officer & Corporate Secretary
- Dr. Philippe Busque Ph.D.Senior Vice President of Global Sales & Services
- Mr. Patrik Sebastian JeanmonodHead of Corporate Development Analytics